Ascendia

  MARKET NEWS

NodThera’s NLRP3 Inhibitor Reverses Neuroinflammation in Parkinson’s Disease Phase 1b/2a Trial
Hovione Partners With Dragonfly Technologies to Offer Micellar Chemistry Technology to Customers as a Sustainable Alternative to Conventional Chemical Processes
Rentschler Biopharma Contributes to Nearly 25% of FDA-Approved Biopharmaceuticals in 2023
Olema Oncology Announces Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type & Mutant ER+ Breast Cancer Both as Monotherapy & in Combination With CDK4/6 Inhibitors
Exclusive License Agreement Secured With Erganeo for EVerGel, EVerZom's Breakthrough Treatment for Fistulas & Fibrosis of the Digestive Tract
Allyx Therapeutics Announces Expansion Into Parkinson’s Disease Clinical Research With Lead Compound Following IND Acceptance

  FEATURED EDITORIAL

  COMPANY PROFILE


LGM Pharma is a leading contract development and manufacturing organization (CDMO) offering a robust suite of capabilities, including comprehensive Active Pharmaceutical Ingredient (API) sourcing, analytical testing services, and drug product CDMO solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries. LGM Pharma assists clients in managing all phases of the drug product development process, from API sourcing through to commercialization. LGM Pharma’s extensive global network of qualified API partners enables clients to optimize supply chain management and distribution. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Genezen Announces Strategic Process Development & Manufacturing Partnership Agreement With Seattle Children’s Research Institute

Genezen Announces Strategic Process Development & Manufacturing Partnership Agreement With Seattle Children’s Research Institute

Seattle Children’s Research Institute and Genezen have unveiled a strategic manufacturing partnership for Seattle Children’s Research Institute’s X-linked agammaglobulinemia….

Adare Pharma Solutions to Expand Packaging & Warehousing Capabilities in Europe

Adare Pharma Solutions to Expand Packaging & Warehousing Capabilities in Europe

Adare Pharma Solutions recently announced that work has begun to add packaging capabilities and further warehousing capacity at its….

BiomX Enters Merger Agreement With Adaptive Phage Therapeutics & Concurrent -Million Financing

BiomX Enters Merger Agreement With Adaptive Phage Therapeutics & Concurrent $50-Million Financing

Acquisition will create phage therapy company with an advanced pipeline with two Phase 2 assets, BX004 for the treatment of chronic pulmonary infections in cystic fibrosis patients and BX211 for the treatment of diabetic foot osteomyelitis….

Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO

Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO

AustinPx, developers of the next generation amorphous dispersion platform, KinetiSol Technology, and a contract development and manufacturing organization (CDMO), recently announced Elizabeth Hickman, Chief Business Officer, will succeed….

  WHITEPAPERS & WEBINARS

 

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lines blurring between traditional chemical synthesis …

TECH BRIEF – Expedite FDA Approvals With Certified Pure Materials

TECH BRIEF – Expedite FDA Approvals With Certified Pure Materials

A key focus of the U.S. Food and Drug Administration’s evaluation of a medical device’s safety and effectiveness is reviewing its material makeup. If improperly tested – and impure materials are used – there is an elevated risk of contamination …

WHITEPAPER - Case Study-Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening

WHITEPAPER - Case Study-Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening

Abstract: A team of bioavailability experts at Catalent used the in-house bioavailability enhancement platform, OptiForm® Solution Suite, to optimize and develop Phase 1 clinical formulation within a short timeline. Catalent’s global supply chain expertise was utilized for packaging and distributing …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 20 – Excipients
March 27 – Prefilled Syringes